TY  - RPRT
TI  - The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate.
AU  - C P Evans
AU  - V Gajendran
AU  - A Tewari
AU  - K Aslam
AU  - R Juster
AU  - S Gange
AU  - A Eason
AU  - P Narayan
PY  - 1996
DO  - 10.1046/j.1464-410x.1996.00079.x
UR  - https://pubmed.ncbi.nlm.nih.gov/8881955/
ID  - 8881955
ER  -